LEUKEMIA, HAIRY CELL
Clinical trials for LEUKEMIA, HAIRY CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, HAIRY CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, HAIRY CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: experimental drug MGD024 enters human testing
Disease control OngoingThis early-stage study tests a new drug called MGD024 in people with certain blood cancers (like leukemia and lymphoma) that came back or didn't get better with standard treatments. The main goal is to find the safest dose and watch for side effects. About 130 adults will receive…
Matched conditions: LEUKEMIA, HAIRY CELL
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New combo therapy shows promise for rare leukemia patients
Disease control OngoingThis study tests a combination of two drugs, vemurafenib (a pill) and obinutuzumab (an infusion), in 30 people with previously untreated hairy cell leukemia. The goal is to see how many patients achieve a complete response, meaning no signs of cancer after treatment. Participants…
Matched conditions: LEUKEMIA, HAIRY CELL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC